Home > Coronavirus vaccine > Page 2

Coronavirus vaccine

Research Briefing

APAC | Recovery Tracker points to stalling momentum

Research Briefing

Denmark | Economy on course for rapid growth this year

Research Briefing

Finland | Economy remains resilient with growth seen, but downside risks are rising

Research Briefing

India | Vaccine surge to energize consumption in 2022

Research Briefing

MENA | Higher oil income to propel GCC diversification efforts

Research Briefing

APAC: Delta-related drags in 2021 but stronger 2022 in view

Blog

“Vaccine apartheid” and Western influence in Africa

Research Briefing

Australia | Recovery tracker falters under weight of lockdowns

Research Briefing

Australia | It’s a race: reopening waiting on vaccine rollout

Research Briefing

Eurozone | Delta variant becomes key downside risk to the outlook

Research Briefing

India | Monetary policy may turn a corner before year-end

Research Briefing

India | Premature state re-openings could backfire

Research Briefing

Global | Coronavirus Watch: Services to drive the recovery

Research Briefing

Global | Coronavirus Watch: The limits of vaccines

Research Briefing

Global | Inflation overshoot possible, but not yet probable

Research Briefing

India | Slow vaccination to prolong lockdowns, lower growth

Research Briefing

India | How the 2021 lockdown is different from 2020

Research Briefing

Global Coronavirus Watch: Time for a re-think on inflation?

Research Briefing

Global | Coronavirus Watch: Why rising inflation isn’t alarming

Research Briefing

Global | Coronavirus Watch: When the chips are down

Find out how Oxford Economics can help you on your path to business growth

Talk to an expert

cta

Please Add Form

Share